Secure Access Required

Cardio AI Investor Data Room

❌ Incorrect password. Please try again.
🛡️ Confidential Information - Authorized Investors Only

🫀 CARDIO AI

Investor Data Room - Confidential Materials
$10.26B
5-Year Revenue
$6.16B
5-Year EBITDA
60%
EBITDA Margin
$187B
TAM
⚠️ CONFIDENTIAL - For Authorized Investors Only

Welcome to the Cardio AI Data Room

Comprehensive investor documentation for Cardio AI, the first unified multi-agent AI platform revolutionizing cardiovascular care. Our platform integrates 3 specialized subsystems coordinated by a Master Orchestrator: CardioAI Platform (7 AI agents), IoMT Platform (real-time monitoring), and PACS/DICOM Platform (medical imaging). With world-class 60% EBITDA margins and profitable from Year 1, we're positioned to capture 20% of the $187B AI healthcare market.

📊 Investment Highlights

Year 1
Profitable from Day 1
1,231x
Return on $5M Seed
2.5M
Members by Year 5
50x
Member Growth
7
Specialized AI Agents
5
Risk Calculators

📋 Core Documents

📥 Document Access: All core documents are available to view online instantly. Click "View Online" on any document card to read it in your browser.

For additional documents or questions, contact us at [email protected]

📄
01 - Executive Summary
Comprehensive company overview including $10.26B revenue projections, $187B TAM, platform architecture, and leadership team.
DOCX • 11KB View Online
🔬
02 - Product Overview & Technology
Complete technical documentation of Unified Master Orchestrator with 3 subsystems: 7 AI agents, IoMT Platform, PACS/DICOM system.
DOCX • 15KB View Online
💰
03 - Financial Model (Optimized)
5-year projections with 40% OpEx and 60% EBITDA margins. Detailed pricing tiers and revenue model.
XLSX • 11KB View Online
📈
04 - Market Analysis
$187B TAM, $52.4B SAM, $10.3B SOM. Detailed competitive landscape and market strategy.
DOCX • 13KB View Online
💼
05 - Investment Memorandum
Complete investment thesis with financials, use of funds, risk factors, and exit strategies.
DOCX • 12KB View Online
📋
06 - Business Plan
Comprehensive strategic plan demonstrating world-class 60% EBITDA margins and $10.26B revenue potential.
DOCX • 18KB View Online
🏆
08 - Competitive Matrix
Complete analysis of 11 major competitors showing Cardio AI's 3-50x advantage across technology, economics, and returns.
HTML • Interactive View Online
📊
09 - Traction & Milestones Matrix
Comprehensive achievements: 6/8 AI agents validated (75% complete), MVP operational, beta program designed for Q1 2026 launch. Demonstrates exceptional execution velocity.
HTML • Interactive View Online
💰
10 - Revenue Analysis (ARR & MRR)
Official 5-year revenue projections: $51M → $4.75B ARR (93x growth). Detailed breakdown of MRR, unit economics (32:1 LTV:CAC), 60% EBITDA margins, and investment returns (840-1,710x expected).
HTML • Interactive View Online

📊 5-Year Financial Summary

Metric Year 1 Year 2 Year 3 Year 4 Year 5
Members 50,000 250,000 1,000,000 1,750,000 2,500,000
Revenue $51M $367M $1.87B $3.22B $4.75B
EBITDA $30.6M $220M $1.12B $1.93B $2.85B
EBITDA Margin 60% 60% 60% 60% 60%